Radiotherapy combined with first-line anti-programmed cell death protein 1 (PD-1) immunotherapy and chemotherapy for patients with advanced non-small cell lung cancer: A bicentric retrospective study
- DOI
- 10.1016/j.cpt.2025.02.007
- Published
- 2025-11
- Container
- Cancer Pathogenesis and Therapy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.cpt.2025.02.007,
title = {Radiotherapy combined with first-line anti-programmed cell death protein 1 (PD-1) immunotherapy and chemotherapy for patients with advanced non-small cell lung cancer: A bicentric retrospective study},
author = {Yu Huang and Peng Ding and Ruiguang Zhang and Yongchang Zhang and Fan Tong and Shishi Cheng and Ling Peng and Xiaohua Jie and Jian Wang and Pian Liu and Sheng Zhang and Gang Wu and Nong Yang and Xiaorong Dong},
year = {2025},
journal = {Cancer Pathogenesis and Therapy},
doi = {10.1016/j.cpt.2025.02.007},
url = {https://doi.org/10.1016/j.cpt.2025.02.007}
}RIS
TY - JOUR TI - Radiotherapy combined with first-line anti-programmed cell death protein 1 (PD-1) immunotherapy and chemotherapy for patients with advanced non-small cell lung cancer: A bicentric retrospective study AU - Yu Huang AU - Peng Ding AU - Ruiguang Zhang AU - Yongchang Zhang AU - Fan Tong AU - Shishi Cheng AU - Ling Peng AU - Xiaohua Jie AU - Jian Wang AU - Pian Liu AU - Sheng Zhang AU - Gang Wu AU - Nong Yang AU - Xiaorong Dong PY - 2025 JO - Cancer Pathogenesis and Therapy DO - 10.1016/j.cpt.2025.02.007 UR - https://doi.org/10.1016/j.cpt.2025.02.007 ER -
APA
Huang, Y., Ding, P., Zhang, R., Zhang, Y., Tong, F., Cheng, S., Peng, L., Jie, X., Wang, J., Liu, P., Zhang, S., Wu, G., Yang, N., & Dong, X. (2025). Radiotherapy combined with first-line anti-programmed cell death protein 1 (PD-1) immunotherapy and chemotherapy for patients with advanced non-small cell lung cancer: A bicentric retrospective study. Cancer Pathogenesis and Therapy. https://doi.org/10.1016/j.cpt.2025.02.007
Source records
- crossref · retrieved 2026-09-24T23:15:37.831Z